Effect of glucocorticoid treatment on BAFF and APRIL expression in patients with immune thrombocytopenia (ITP)
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 188, 74-80
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (SA-405 4-1)
This publication has 56 references indexed in Scilit:
- B cell activating factor in obesity is regulated by oxidative stress in adipocytesJournal of Clinical Biochemistry and Nutrition, 2013
- Solar Radiation and Vitamin D: Mitigating Environmental Factors in Autoimmune DiseaseJournal of Environmental and Public Health, 2012
- ITP: Tolerance LostBlood, 2011
- Reduced antioxidant capacities in platelets from patients with autoimmune thrombocytopenia purpura (ITP)Platelets, 2011
- Glucocorticoids in the treatment of neonatal meconium aspiration syndromeEuropean Journal of Pediatrics, 2011
- Mitochondrial Localization of Vitamin D Receptor in Human Platelets and Differentiated MegakaryocytesPLOS ONE, 2010
- Raised serum APRIL levels in patients with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2005
- T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpuraNature Medicine, 2003
- RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILNature Immunology, 2002
- Immune ThrombocytopeniaNew England Journal of Medicine, 1979